These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 8027180)

  • 21. Zonal distribution of transcripts of four hepatic transcription factors in the mature rat liver.
    Lindros KO; Oinonen T; Issakainen J; Nagy P; Thorgeirsson SS
    Cell Biol Toxicol; 1997 Jul; 13(4-5):257-62. PubMed ID: 9298246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Competition between transcription factors HNF1 and HNF3, and alternative cell-specific activation by DBP and C/EBP contribute to the regulation of the liver-specific aldolase B promoter.
    Gregori C; Kahn A; Pichard AL
    Nucleic Acids Res; 1993 Feb; 21(4):897-903. PubMed ID: 8383844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte nuclear factor 4 expression overcomes repression of the hepatic phenotype in dedifferentiated hepatoma cells.
    Späth GF; Weiss MC
    Mol Cell Biol; 1997 Apr; 17(4):1913-22. PubMed ID: 9121439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2).
    Qadri I; Hu LJ; Iwahashi M; Al-Zuabi S; Quattrochi LC; Simon FR
    Toxicol Appl Pharmacol; 2009 Feb; 234(3):281-92. PubMed ID: 19010343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional activators in hepatocytes.
    Johnson PF
    Cell Growth Differ; 1990 Jan; 1(1):47-52. PubMed ID: 2078499
    [No Abstract]   [Full Text] [Related]  

  • 26. Expression of the liver-enriched transcription factors C/EBP alpha, C/EBP beta, HNF-1, and HNF-4 in preneoplastic nodules and hepatocellular carcinoma in rat liver.
    Flodby P; Liao DZ; Blanck A; Xanthopoulos KG; Hällström IP
    Mol Carcinog; 1995 Feb; 12(2):103-9. PubMed ID: 7662115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the rat hepatocyte nuclear factor (HNF) 1 gene promoter: synergistic activation by HNF4 and HNF1 proteins.
    Miura N; Tanaka K
    Nucleic Acids Res; 1993 Aug; 21(16):3731-6. PubMed ID: 8367288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterning the expression of a tissue-specific transcription factor in embryogenesis: HNF1 alpha gene activation during Xenopus development.
    von Strandmann EP; Nastos A; Holewa B; Senkel S; Weber H; Ryffel GU
    Mech Dev; 1997 Jun; 64(1-2):7-17. PubMed ID: 9232592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [On the role of liver-enriched transcription factors in regulating HBV transcription and replication].
    Wang S; Tang H; He F; Liu L; Huang FJ; Zhou TY; Zhao LS
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):35-9. PubMed ID: 16468637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of transacting factors responsible for the tissue-specific expression of human glucose transporter type 2 isoform gene. Cooperative role of hepatocyte nuclear factors 1alpha and 3beta.
    Cha JY; Kim H; Kim KS; Hur MW; Ahn Y
    J Biol Chem; 2000 Jun; 275(24):18358-65. PubMed ID: 10748140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interplay of an original combination of factors: C/EBP, NFY, HNF3, and HNF1 in the rat aldolase B gene promoter.
    Raymondjean M; Pichard AL; Gregori C; Ginot F; Kahn A
    Nucleic Acids Res; 1991 Nov; 19(22):6145-53. PubMed ID: 1956774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressed expression of the urea cycle enzyme genes in the liver of carnitine-deficient juvenile visceral steatosis (JVS) mice in infancy and during starvation in adulthood.
    Tomomura M; Tomomura A; Musa DA; Horiuchi M; Takiguchi M; Mori M; Saheki T
    J Biochem; 1997 Jan; 121(1):172-7. PubMed ID: 9058209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver-enriched transcription factors, HNF-1, HNF-3, and C/EBP, are major contributors to the strong activity of the chicken CYP2H1 promoter in chick embryo hepatocytes.
    Dogra SC; May BK
    DNA Cell Biol; 1997 Dec; 16(12):1407-18. PubMed ID: 9428789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoderm-specific gene expression in embryonic stem cells differentiated to embryoid bodies.
    Abe K; Niwa H; Iwase K; Takiguchi M; Mori M; Abé SI; Abe K; Yamamura KI
    Exp Cell Res; 1996 Nov; 229(1):27-34. PubMed ID: 8940246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of MMH (Met murine hepatocyte) cell differentiation by TGF(beta) is abrogated by pre-treatment with the heritable differentiation effector FGF1.
    Spagnoli FM; Cicchini C; Tripodi M; Weiss MC
    J Cell Sci; 2000 Oct; 113 ( Pt 20)():3639-47. PubMed ID: 11017879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte nuclear factor 4 (HNF4) binding sites in the salmon HNF1 promoter.
    Deryckere F; McNair A; Gannon F
    Gene; 1996 Oct; 175(1-2):35-41. PubMed ID: 8917073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexistence of C/EBP alpha, beta, growth-induced proteins and DNA synthesis in hepatocytes during liver regeneration. Implications for maintenance of the differentiated state during liver growth.
    Greenbaum LE; Cressman DE; Haber BA; Taub R
    J Clin Invest; 1995 Sep; 96(3):1351-65. PubMed ID: 7657810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective loss of the hepatic phenotype due to the absence of a transcriptional activation pathway.
    Bulla GA
    Somat Cell Mol Genet; 1997 May; 23(3):185-201. PubMed ID: 9330630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoic acid mediates down-regulation of the alpha-fetoprotein gene through decreased expression of hepatocyte nuclear factors.
    Magee TR; Cai Y; El-Houseini ME; Locker J; Wan YJ
    J Biol Chem; 1998 Nov; 273(45):30024-32. PubMed ID: 9792724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.
    Günther S; Piwon N; Iwanska A; Schilling R; Meisel H; Will H
    J Virol; 1996 Dec; 70(12):8318-31. PubMed ID: 8970951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.